GURUFOCUS.COM » STOCK LIST » USA » NAS » SomaLogic Inc (NAS:SLGC) » Definitions » EV-to-EBITDA
Switch to:

SomaLogic EV-to-EBITDA

: -11.29 (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SomaLogic's enterprise value is $759.64 Mil. SomaLogic's EBITDA for the trailing twelve months (TTM) ended in Mar. 2022 was $-67.29 Mil. Therefore, SomaLogic's EV-to-EBITDA for today is -11.29.

The historical rank and industry rank for SomaLogic's EV-to-EBITDA or its related term are showing as below:

SLGC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -22.36   Med: -6.45   Max: -1.77
Current: -10.06

During the past 2 years, the highest EV-to-EBITDA of SomaLogic was -1.77. The lowest was -22.36. And the median was -6.45.

SLGC's EV-to-EBITDA is ranked worse than
100% of 455 companies
in the Healthcare Providers & Services industry
Industry Median: 12.93 vs SLGC: -10.06

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2022-08-09), SomaLogic's stock price is $4.61. SomaLogic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.700. Therefore, SomaLogic's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


SomaLogic EV-to-EBITDA Historical Data

The historical data trend for SomaLogic's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomaLogic Annual Data
Trend Dec20 Dec21
EV-to-EBITDA
- -17.40

SomaLogic Quarterly Data
Sep20 Dec20 Mar21 Sep21 Dec21 Mar22
EV-to-EBITDA Premium Member Only - - -32.38 -17.40 -12.09

Competitive Comparison

For the Health Information Services subindustry, SomaLogic's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

SomaLogic EV-to-EBITDA Distribution

For the Healthcare Providers & Services industry and Healthcare sector, SomaLogic's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SomaLogic's EV-to-EBITDA falls into.



SomaLogic EV-to-EBITDA Calculation

SomaLogic's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=759.637/-67.288
=-11.29

SomaLogic's current Enterprise Value is $759.64 Mil.
SomaLogic's EBITDA for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-67.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SomaLogic  (NAS:SLGC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

SomaLogic's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.61/-0.700
=At Loss

SomaLogic's share price for today is $4.61.
SomaLogic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.700.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


SomaLogic EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SomaLogic's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


SomaLogic Business Description

SomaLogic logo
Traded in Other Exchanges
Address
2945 Wilderness Place, Boulder, CO, USA, 80301
SomaLogic Inc delivers precise and actionable health-management information that helps individuals to optimize their personal health and wellness throughout their lives. This information, to be provided through a global network of partners and users, is derived from SomaLogic's personalized measurement of changes in an individual's proteins over time.
Executives
Blakeman Shaun M. officer: Chief Financial Officer C/O CANTEL MEDICAL CORP. 150 CLOVE ROAD LITTLE FALLS NJ 07424
Margulies Anne H. director C/O HENRY SCHEIN, INC. 135 DURYEA ROAD MELVILLE NY 11747
Post Richard A director 998 LACOSTA LANE LANE TREE CO 80124
Casdin Eli director 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019
Cox Troy director C/O FOUNDATION MEDICINE, INC. C/O FOUNDATION MEDICINE, INC., 150 SECON CAMBRIDGE MA 02141
Meisel Ted D director
Barchi Robert director
Quake Stephen director C/O FLUIDIGM CORPORATION 7000 SHORELINE COURT, SUITE 100 SOUTH SAN FRANCISCO CA 94080
Lillis Charles M. director 13 CASTLE PINES DRIVE N CASTLE ROCK CO 80108
Harris Melody officer: President and COO 4801 WEST BYRON PLACE DENVER CO 80211
Gutierrez Ruben officer: General Counsel 6435 AVENIDA WILFREDO LA JOLLA CA 92037
Graves Amy officer: Chief Accounting Officer 926 PENDLETON AVENUE LONGMONT CO 80504
Smythe Roy director, officer: Chief Executive Officer 935 10TH STREET BOULDER CO 80302
M-lsh Ii Llc 10 percent owner 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065
C-lsh Ii Llc 10 percent owner 1350 6TH AVENUE SUITE 2600 NEW YORK NY 10019

SomaLogic Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)